NUAGO
Live / Registered — Registered (as of 12 Sept 2023)
What this means for you
Registered since 12 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97177121
- Registration number
- 7165478
- Mark type
- Stylized text
- Filed
- 17 Dec 2021
- Published for opposition
- 01 Nov 2022
- Registered
- 12 Sept 2023
- Attorney of record
- Vivek Jayaram
Goods and services
- Class 042 — Scientific and technological services: Medical research and development services in the field of cancer; providing medical and scientific research information in the field of clinical trials for cancer
Owner
- NUAgo Therapeutics, Inc., Chicago, IL, US
- NUAgo Therapeutics, Inc., Chicago, IL, US
- NUAgo Therapeutics, Inc., Chicago, IL, US
Prosecution history
- 12 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 09 Aug 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Jul 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Jun 2023 — USE AMENDMENT FILED
- 20 Jul 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jun 2023 — TEAS STATEMENT OF USE RECEIVED
- 20 Jan 2023 — ASSIGNED TO EXAMINER
- 27 Dec 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Nov 2022 — PUBLISHED FOR OPPOSITION
- 12 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Sept 2022 — ASSIGNED TO EXAMINER